![]() ![]() Forward-looking statements may include, but are not limited to, statements relating to the Company’s objectives, plans and strategies, and all statements, other than statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. Investment information can be found at Certain statements and information in this press release may be deemed to contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended. To learn more about Pediatrix, visit or follow us on Facebook, Instagram, LinkedIn, Twitter and the Pediatrix blog. The physician-led company was founded in 1979 as a single neonatology practice and today provides its highly specialized and often critical care services through more than 4,800 affiliated physicians and other clinicians in 37 states and Puerto Rico. The group’s high-quality, evidence-based care is bolstered by significant investments in research, education, quality-improvement and safety initiatives. Specialties include obstetrics, maternal-fetal medicine and neonatology complemented by more than 20 pediatric subspecialties, as well as a newly expanded area of pediatric primary and urgent care clinics. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. (NYSE: MD) is the nation’s leading provider of physician services. These factors, which were part of the bipartisan legislation, are important to Pediatrix, as the nation’s leading provider of very high-acuity and broad-based care to mothers, babies and children.įinally, Pediatrix is pleased that the Departments intend future rules, which the Company expects will provide more clarity and better protection for the doctor-patient relationship. These factors are:ġ) The level of training, experience, and quality and outcomes measurements of the provider or facility that furnished the qualified IDR item or service (such as those endorsed by the consensus-based entity authorized in section 1890 of the Social Security Act).Ģ) The market share held by the provider or facility or that of the plan or issuer in the geographic region in which the qualified IDR item or service was provided.ģ) The acuity of the participant, beneficiary, or enrollee who received the qualified IDR item or service, or the complexity of furnishing the qualified IDR item or service to the participant, beneficiary, or enrollee.Ĥ) The teaching status, case mix, and scope of services of the facility that furnished the qualified IDR item or service, if applicable.ĥ) Demonstration of good faith efforts (or lack thereof) made by the provider or facility or the plan or issuer to enter into network agreements with each other, and, if applicable, contracted rates between the provider or facility and the plan or issuer during the previous four plan years. The final rule states that a qualifying payment amount (QPA), described as a calculation of a median in-network rate, is only one of multiple inputs to be considered by the arbitrators in the independent dispute resolution (IDR) process by which out-of-network providers and insurers are required to arbitrate payment rates, and that the very important non-QPA factors must also be considered by the arbitrators. (NYSE: MD) today provided commentary on the final rule issued on Augby the Departments of the Treasury, Labor, and Health and Human Services related to the No Surprises Act. FORT LAUDERDALE, Fla., August 22, 2022-( BUSINESS WIRE)-Pediatrix Medical Group, Inc. ![]()
0 Comments
Leave a Reply. |